Deep Track Biotechnology Master Fund, Ltd.

Related company / holding

Dynavax Technologies CorpLB Pharmaceuticals IncAttovia Therapeutics, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€34.1M

▼ Sales (2 ops.)

€19.2M

Latest filing published 10 Aug 2026 for Attovia Therapeutics, Inc..

Filing timeline

BuySale

Deep Track Biotechnology Master Fund, Ltd.

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Deep Track Biotechnology Master Fund, Ltd.: trading record in brief

This profile gathers the share dealings of Deep Track Biotechnology Master Fund, Ltd. across 3 companies, led by Dynavax Technologies Corp, LB Pharmaceuticals Inc and Attovia Therapeutics, Inc. In total, 7 filings cover trades dated from 21 August 2025 to 6 August 2026.

On the open market, the record shows 2 purchases worth €34.1M and 2 sales worth €19.2M. Taken together, the purchases exceed the sales by €14.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 10 August 2026 with a transaction in Attovia Therapeutics, Inc. The last insider purchase was made public on 16 September 2025, 402 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.